Literature DB >> 24998586

Expression and characterization of protein Latcripin-3, an antioxidant and antitumor molecule from Lentinula edodes C91-3.

Xiao-Hua Ann1, Yong-Zhi Lun, Wei Zhang, Ben Liu, Xing-Yun Li, Min-Tao Zhong, Xiao-Li Wang, Jing Cao, An-Hong Ning, Min Huang.   

Abstract

In this study, an anti-oxidant and anti-tumor protein Latcripin-3 of Lentinula edodes C91-3 was expressed in Escherichia coli. for the first time. According to the cDNA library, the full-length gene of Latcripin-3 was cloned by the methods of 3'-full rapid amplification of cDNA Ends (RACE) and 5'-full RACE. The structural domain gene of Latcripin-3 was inserted into the pET32 a(+). The functional protein of Latcripin-3 was expressed in Rosetta-gami (DE3) E. coli, evaluated by Western blotting and mass spectrometry. DPPH testing showed that the protein Latcripin-3 can scavenge free radicals remarkably well. The activity of functional protein Latcripin-3 on A549 cells was studied with flow cytometry and the MTT method. The MTT assay results showed that there was a decreases in cell viability in a dose-dependent and time-dependent manner in protein Latcripin-3 treated groups. Flow cytometry demonstrated that Latcripin-3 can induce apoptosis and block S phase dramatically in human A549 lung cancer cells as compared to the control group. At the same time, the cell ultrastructure observed by transmission electron microscopy supported the results of flow cytometry. This research offers new insights and advantages for identifying anti-oxidant and anti-tumor proteins.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24998586     DOI: 10.7314/apjcp.2014.15.12.5055

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

1.  Latcripin-7A, derivative of Lentinula edodes C91-3, reduces migration and induces apoptosis, autophagy, and cell cycle arrest at G1 phase in breast cancer cells.

Authors:  Syed Riaz Ud Din; Mintao Zhong; Muhammad Azhar Nisar; Muhammad Zubair Saleem; Akbar Hussain; Kavish H Khinsar; Shahid Alam; Gohar Ayub; Sadia Kanwal; Xingyun Li; Wei Zhang; Xiaoli Wang; Anhong Ning; Jing Cao; Min Huang
Journal:  Appl Microbiol Biotechnol       Date:  2020-10-12       Impact factor: 4.813

Review 2.  Mushroom Polysaccharide-Assisted Anticarcinogenic Mycotherapy: Reviewing Its Clinical Trials.

Authors:  Iyyakkannu Sivanesan; Manikandan Muthu; Judy Gopal; Jae-Wook Oh
Journal:  Molecules       Date:  2022-06-25       Impact factor: 4.927

Review 3.  A Preclinical Evaluation of the Antitumor Activities of Edible and Medicinal Mushrooms: A Molecular Insight.

Authors:  Thomson Patrick Joseph; Warren Chanda; Arshad Ahmed Padhiar; Samana Batool; Shao LiQun; MinTao Zhong; Min Huang
Journal:  Integr Cancer Ther       Date:  2017-11-02       Impact factor: 3.279

4.  LP1 from Lentinula edodes C91-3 Induces Autophagy, Apoptosis and Reduces Metastasis in Human Gastric Cancer Cell Line SGC-7901.

Authors:  Samana Batool; Thomson Patrick Joseph; Mushraf Hussain; Miza S Vuai; Kavish H Khinsar; Syed Riaz Ud Din; Arshad Ahmed Padhiar; Mintao Zhong; Anhong Ning; Wei Zhang; Jing Cao; Min Huang
Journal:  Int J Mol Sci       Date:  2018-09-30       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.